These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 13409287

  • 21. Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine.
    JACQUEZ JA, HUTCHISON DJ.
    Cancer Res; 1959 May; 19(4):397-401. PubMed ID: 13652124
    [No Abstract] [Full Text] [Related]

  • 22. Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors.
    KELLY HJ, SKIPPER HE, TOMISEK AJ.
    Arch Biochem Biophys; 1956 Oct; 64(2):437-55. PubMed ID: 13363451
    [No Abstract] [Full Text] [Related]

  • 23. Transport mechanisms of 6-diazo-5-oxo-L-norleucine in Escherichia coli K-12.
    Williams MV.
    Microbiologica; 1982 Jan; 5(1):57-61. PubMed ID: 7050636
    [Abstract] [Full Text] [Related]

  • 24. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studies.
    COFFEY GL, EHRLICH J, FISHER MW, HILLEGAS AB, KOHBERGER DL, MACHAMER HE, RIGHTSEL WA, ROEGNER FR.
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):487-97. PubMed ID: 24544086
    [No Abstract] [Full Text] [Related]

  • 25. Effect of 6 diazo 5 oxo l-norleucine on the rat litter in utero.
    THIERSCH JB.
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):33-5. PubMed ID: 13400863
    [No Abstract] [Full Text] [Related]

  • 26. The effect of 6-diazo-5-oxo-1-norleucine (DON) on pregnancy.
    JACKSON D, ROBSON JM, WANDER AC.
    J Endocrinol; 1959 Mar; 18(2):204-7. PubMed ID: 13641559
    [No Abstract] [Full Text] [Related]

  • 27. The amination of inosinic acid to adenylic acid in muscle extracts.
    YEFIMOCHKINA EF, BRAUNSTEIN AE.
    Arch Biochem Biophys; 1959 Jul; 83(1):350-2. PubMed ID: 13662023
    [No Abstract] [Full Text] [Related]

  • 28. [Research on the cytological modalities and the biochemical mechanism of the activity of the inhibitors of nucleic metabolism: diaza-oxo-norleucine and azaserine].
    TRUHAUT R, DEYSSON G.
    Bull Soc Chim Biol (Paris); 1961 Jul; 43():227-38. PubMed ID: 13778269
    [No Abstract] [Full Text] [Related]

  • 29. Alterations in calcium metabolism in cancer patients treated with 6-diazo-5-oxo-L-norleucine.
    MAGILL GB, MYERS WP.
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):314-8. PubMed ID: 13379496
    [No Abstract] [Full Text] [Related]

  • 30. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity.
    Cadman E, Benz C, Heimer R, O'Shaughnessy J.
    Biochem Pharmacol; 1981 Sep 01; 30(17):2469-72. PubMed ID: 21043247
    [Abstract] [Full Text] [Related]

  • 31. Purine metabolism in bacteria. IV. L-azaserine as an inhibitor.
    GOLLUB EG, GOTS JS.
    J Bacteriol; 1956 Dec 01; 72(6):858-64. PubMed ID: 13398378
    [No Abstract] [Full Text] [Related]

  • 32. Mutagenic effect of azaserine in relation to azaserine resistance in Escherichia coli.
    IYER VN, SZYBALSKI W.
    Science; 1959 Mar 27; 129(3352):839-40. PubMed ID: 13635022
    [Abstract] [Full Text] [Related]

  • 33. 6-DIAZO-5-OXO-L-NORLEUCINE INHIBITION OF ESCHERICHIA COLI.
    COGGIN JH, MARTIN WR.
    J Bacteriol; 1965 May 27; 89(5):1348-53. PubMed ID: 14293024
    [Abstract] [Full Text] [Related]

  • 34. Slow freezing of carp muscle and inosinic acid formation.
    SAITO T, ARAI K.
    Arch Biochem Biophys; 1958 Feb 27; 73(2):315-9. PubMed ID: 13509717
    [No Abstract] [Full Text] [Related]

  • 35. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
    Catane R, Von Hoff DD, Glaubiger DL, Muggia FM.
    Cancer Treat Rep; 1979 Jun 27; 63(6):1033-8. PubMed ID: 380801
    [Abstract] [Full Text] [Related]

  • 36. Variation in resistance patterns in different neoplasms.
    POTTER M.
    Ann N Y Acad Sci; 1958 Dec 05; 76(3):630-42. PubMed ID: 13627890
    [No Abstract] [Full Text] [Related]

  • 37. Mode of action of azaserine on Gaffkya homari.
    AARONSON S.
    J Bacteriol; 1959 May 05; 77(5):548-51. PubMed ID: 13654215
    [No Abstract] [Full Text] [Related]

  • 38. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.
    Takada Y, Greig NH, Vistica DT, Rapoport SI, Smith QR.
    Cancer Chemother Pharmacol; 1991 May 05; 29(2):89-94. PubMed ID: 1760863
    [Abstract] [Full Text] [Related]

  • 39. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC, Seegmiller JE.
    J Cell Physiol; 1977 Dec 05; 93(3):375-82. PubMed ID: 22551
    [Abstract] [Full Text] [Related]

  • 40. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H, KURAHORI T, KUSUMOTO G, TERASHITA N, TABUCHI Y, ICHIHARA G, TOKITA Y, IKEDA E, FUKUI S.
    Gan; 1956 Dec 05; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.